T296→M, a common mutation causing mild hemophilia B in the Amish and others

founder effect, variability in factor IX activity assays, and rapid carrier detection

Rhett P. Ketterling, Cynthia D K Bottema, Dwight D. Koeberl, Setsuko Ii, Steve S. Sommer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

By direct genomic sequencing, we have delineated the causative mutation in 64 families of European descent with hemophilia B. Six (9%) had a C→T transition at base 31008, which substitutes methionine for threonine 296 (T296→M) in the catalytic domain of factor IX. Five of the patients had the same haplotype (frequency of 16% in the northern European population). These individuals are of Amish/German descent and they are likely to share a common ancestor. The sixth patient had a different haplotype, which indicates that his mutation had an independent origin. The data highlight the importance of clinical criteria for the classification of hemophilia B. All six patients had clinically mild disease and their factor IX coagulant activities were in the range of 3%-6% when tested simultaneously in one laboratory, yet the factor IX activities provided with patient records varied 40-fold. Due to the high frequency of this mutation, we have utilized the technique of polymerase chain reaction amplification of specific alleles (PASA) to perform rapid and inexpensive carrier diagnoses in the families with this mutation. This is of particular importance for the Amish since the mutation should account for much of, if not all, the mild hemophilia B that is commonly found in this population.

Original languageEnglish (US)
Pages (from-to)333-337
Number of pages5
JournalHuman Genetics
Volume87
Issue number3
DOIs
StatePublished - Jul 1991

Fingerprint

Amish
Founder Effect
Hemophilia B
Factor IX
Mutation
Haplotypes
Coagulants
Mutation Rate
Threonine
Methionine
Population
Catalytic Domain
Alleles
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

T296→M, a common mutation causing mild hemophilia B in the Amish and others : founder effect, variability in factor IX activity assays, and rapid carrier detection. / Ketterling, Rhett P.; Bottema, Cynthia D K; Koeberl, Dwight D.; Ii, Setsuko; Sommer, Steve S.

In: Human Genetics, Vol. 87, No. 3, 07.1991, p. 333-337.

Research output: Contribution to journalArticle

Ketterling, Rhett P. ; Bottema, Cynthia D K ; Koeberl, Dwight D. ; Ii, Setsuko ; Sommer, Steve S. / T296→M, a common mutation causing mild hemophilia B in the Amish and others : founder effect, variability in factor IX activity assays, and rapid carrier detection. In: Human Genetics. 1991 ; Vol. 87, No. 3. pp. 333-337.
@article{cb1c39c43ff741148ab1ee84a4b9515e,
title = "T296→M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection",
abstract = "By direct genomic sequencing, we have delineated the causative mutation in 64 families of European descent with hemophilia B. Six (9{\%}) had a C→T transition at base 31008, which substitutes methionine for threonine 296 (T296→M) in the catalytic domain of factor IX. Five of the patients had the same haplotype (frequency of 16{\%} in the northern European population). These individuals are of Amish/German descent and they are likely to share a common ancestor. The sixth patient had a different haplotype, which indicates that his mutation had an independent origin. The data highlight the importance of clinical criteria for the classification of hemophilia B. All six patients had clinically mild disease and their factor IX coagulant activities were in the range of 3{\%}-6{\%} when tested simultaneously in one laboratory, yet the factor IX activities provided with patient records varied 40-fold. Due to the high frequency of this mutation, we have utilized the technique of polymerase chain reaction amplification of specific alleles (PASA) to perform rapid and inexpensive carrier diagnoses in the families with this mutation. This is of particular importance for the Amish since the mutation should account for much of, if not all, the mild hemophilia B that is commonly found in this population.",
author = "Ketterling, {Rhett P.} and Bottema, {Cynthia D K} and Koeberl, {Dwight D.} and Setsuko Ii and Sommer, {Steve S.}",
year = "1991",
month = "7",
doi = "10.1007/BF00200915",
language = "English (US)",
volume = "87",
pages = "333--337",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - T296→M, a common mutation causing mild hemophilia B in the Amish and others

T2 - founder effect, variability in factor IX activity assays, and rapid carrier detection

AU - Ketterling, Rhett P.

AU - Bottema, Cynthia D K

AU - Koeberl, Dwight D.

AU - Ii, Setsuko

AU - Sommer, Steve S.

PY - 1991/7

Y1 - 1991/7

N2 - By direct genomic sequencing, we have delineated the causative mutation in 64 families of European descent with hemophilia B. Six (9%) had a C→T transition at base 31008, which substitutes methionine for threonine 296 (T296→M) in the catalytic domain of factor IX. Five of the patients had the same haplotype (frequency of 16% in the northern European population). These individuals are of Amish/German descent and they are likely to share a common ancestor. The sixth patient had a different haplotype, which indicates that his mutation had an independent origin. The data highlight the importance of clinical criteria for the classification of hemophilia B. All six patients had clinically mild disease and their factor IX coagulant activities were in the range of 3%-6% when tested simultaneously in one laboratory, yet the factor IX activities provided with patient records varied 40-fold. Due to the high frequency of this mutation, we have utilized the technique of polymerase chain reaction amplification of specific alleles (PASA) to perform rapid and inexpensive carrier diagnoses in the families with this mutation. This is of particular importance for the Amish since the mutation should account for much of, if not all, the mild hemophilia B that is commonly found in this population.

AB - By direct genomic sequencing, we have delineated the causative mutation in 64 families of European descent with hemophilia B. Six (9%) had a C→T transition at base 31008, which substitutes methionine for threonine 296 (T296→M) in the catalytic domain of factor IX. Five of the patients had the same haplotype (frequency of 16% in the northern European population). These individuals are of Amish/German descent and they are likely to share a common ancestor. The sixth patient had a different haplotype, which indicates that his mutation had an independent origin. The data highlight the importance of clinical criteria for the classification of hemophilia B. All six patients had clinically mild disease and their factor IX coagulant activities were in the range of 3%-6% when tested simultaneously in one laboratory, yet the factor IX activities provided with patient records varied 40-fold. Due to the high frequency of this mutation, we have utilized the technique of polymerase chain reaction amplification of specific alleles (PASA) to perform rapid and inexpensive carrier diagnoses in the families with this mutation. This is of particular importance for the Amish since the mutation should account for much of, if not all, the mild hemophilia B that is commonly found in this population.

UR - http://www.scopus.com/inward/record.url?scp=0025923464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025923464&partnerID=8YFLogxK

U2 - 10.1007/BF00200915

DO - 10.1007/BF00200915

M3 - Article

VL - 87

SP - 333

EP - 337

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 3

ER -